Category Archives: Featured

50th Union World Conference on Lung Health: Socioeconomic support improves TB prevention

By on .

HYDERABAD, INDIA – Accelerating efforts to prevent tuberculosis wherever it is treated has been the rallying cry in Hyderabad during this conference. One study shows that providing financial incentives plus social support not only improves TB treatment completion but increases TB screening and preventative therapy uptake among household members of TB patients. “TB is the archetypal […]

What we’re reading: Harm in immigrant detention facilities and what needs to happen when children die in U.S. custody

By on .

A natural death: The political battlefield of infections and migrant children’s bodies – Tracing the events surrounding the death of eight-year-old Felipe Alonso Gomez in U.S. custody, Dr. Mark Travassos makes a compelling case for advocacy and action to expose and end harrowing violations of health and human rights in immigrant detention facilities. From the […]

IDWeek: Ending HIV as an epidemic will demand innovation, inclusion, an expanded workforce — and funding

By on .

As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades into an epidemic that has taken the lives more than 700,000 people in America, still close to 40,000 people in this country are diagnosed with HIV here each year. […]

A “Big IDea” takes infectious disease education and advocacy to Washington

By on .

A day before the opening of the  joint annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, the HIV Medical Association, and the Pediatric Infectious Diseases Society in Washington, DC, about 70 infectious diseases and HIV specialists, researchers and clinicians came to town for a day of educating their […]

Treatment rationing, other structural barriers stand in the way of stopping spread of hepatitis C among people living with HIV, study finds

By on .

When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of liver damage — to make the medicines universally accessible, the numbers of people who accessed the treatment nearly doubled, a study reported in Clinical Infectious Diseases found. New initiation […]

New TB drug approval a milestone, all agree — with caveats, some add

By on .

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]

Amid other challenges, Burundi begins front-line, health worker Ebola vaccinations at border

By on .

DRC neighbor boosts preparedness for spread of virus while grappling with increasing malaria cases, continued cholera outbreak Burundi’s health ministry Tuesday launched a campaign to vaccinate  health workers and others on the front line of a Democratic Republic of Congo border crossing Tuesday, the most recent in a series of steps preparing for the eventuality […]

Improved Ebola survival rates with study treatments raise hopes, challenges

By on .

Announcing favorable results from two of four Ebola treatment candidates being used in a randomized clinical trial among patients in the ongoing Democratic Republic of Congo outbreak, officials from the National Institute of Allergy and Infectious Diseases, the World Health Organization, and a veteran Democratic Republic of Congo researcher today heralded preliminary data as yielding […]

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

By on .

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. If 90 percent of all people living with the virus knew it, 90 percent of them access antiretroviral treatment, and 90 percent of those on treatment — that is […]

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

By on .

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]